Congratulations to the 11 newly designated Antimicrobial Stewardship Center of Excellence 🎉: -King Salman bin Abdulaziz Medical City -Cohen Children's Medical Center (@NorthwellHealth) -Staten Island University Hospital (@NorthwellHealth) -East Jefferson General Hospital (@EJHospital) -Le Bonheur Children's Hospital (@LeBonheurChild) -Mosaic Life Care (@Mosaic_LifeCare) -Tampa General Hospital (@TGHCares) -Emory University Hospital Midtown -New York City Health Hospitals/Elmhurst (@NYCHealthSystem) -University Hospital (@UnivHospNewark) -Audie L. Murphy Memorial VA Hospital Learn more: bit.ly/4xi7z90

Have you ever heard of the Eagle effect? When more kills less. One of microbiology's most intriguing paradoxes: sometimes higher antibiotic concentrations result in less bacterial killing. This phenomenon has even been proposed as a potential rationale for combination therapy.

Sigh. STATIC AND CIDAL IS NOT A THING! Okay. Okay. Okay. Im doing some deep breathing here. Okay. Im calmer now. Let's begin the tweetorial. First, forget static/cidal, the regimen you describe is not unreasonable. We'll come back to static and cidal in a minute. Second...

Adenovirus Infections and Disease in Solid Organ Transplant Recipients @OFIDJournal @TheTxIDjournal onlinelibrary.wiley.com/doi/… academic.oup.com/ofid/articl…

Leptospirosis—clinical review and updates on therapeutics | The Lancet Infectious Diseases (2026) thelancet.com/journals/lanin…

Clin Microbiol Infect. 2026 Feb 16:S1198-743X(26)00069-8. 「抗菌薬アレルギーの評価とマネジメント」 ESCMIDのガイドライン、実臨床で結構使えそう。 clinicalmicrobiologyandinfec…

Does prolonged postoperative antibiotics reduce surgical site infections (SSI)? 📚 69 randomized controlled trials 👥 21,243 patients 🏥 Multiple surgical specialties ➡️ No added benefit of extending antibiotics after surgery completion iris.who.int/items/c24efb84-…

السلام عليكم ورحمة الله وبركاته أكملت اليوم تصميم مخطط جديد يوضح تصنيف (Gram Negative Bacteria)، ليكون مكمّل لسلسلة المخططات السابقة الخاصة بتصنيف (Gram Positive Bacteria) أسأل الله أن أكون وُفقت في تقديم مادة نافعة، وأسأل الله لي ولكم التوفيق والسداد. اخوكم جمال الربيعي

Biomarkers in the Diagnosis of Aspergillosis doi.org/10.3390/jof12040259

A guideline from the American College of Gastroenterology recommends rifabutin triple therapy or potassium-competitive acid blocker-based regimens for treatment-naive adults with #Helicobacterpylori infection unable to receive bismuth quadruple therapy. ja.ma/4sok9Rg

Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP)

LANCET 2026: Seminar SEPSIS doi.org/10.1016/S0140-6736(2… #MedEd #MedTwitter #MedX medicina-interna.org

The shift from “MIC-Only” back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance, mini review - Journal of Clinical Microbiology (2026) journals.asm.org/doi/10.1128…

☕️It's the weekend. Time to relax, unwind...and casually thumb thru some recent ID phase 3 clinical trials

لقيت موقع عجيب جدًا ! للطب،الصيدلة،والاسنان يحسب لك موزونتك للريزدنسي. تدخل المعدل، ودرجة الهيئة المتوقعة او الفعلية، ونشاطات الـCV، وهو يعطيك الموزونة ويقارنها بقبولات السنة الماضية في كل المناطق. النتيجة توضح لك إذا وضعك قوي أو تحتاج ترفع درجاتك scfhs-calculator.com/start

🧬Culture-Negative Bacteria (CNB)|IJID | 2025 🚀 What they did • Reviewed CNB pathogens: Bartonella, Coxiella, Rickettsia, Orientia, Leptospira 🦠 • Assessed why they evade culture, escape detection, and stay off global priority lists 🧪❌ • Evaluated incidence, mortality, diagnostics, surveillance, and AMS/AMR impact 🌍💊 🔥 Key findings • CNB = major causes of fever in LMICs but routinely missed by standard tests 🧫🚫 • Diagnostics limited: low PCR sensitivity, imperfect serology, intracellular growth 🧬⚠️ • In many regions, CNB match or exceed BPPL pathogens in incidence 📈🌡️ • High mortality risks: — Q fever/Bartonella endocarditis up to 40% 💔 — Scrub typhus CFR 0–70% 😷 — Leptospirosis with pulmonary hemorrhage >70% 🩸 • Not included in WHO NTD/BPPL lists despite meeting key criteria 📝🔍 • Underdiagnosis → inappropriate antibiotics, driving AMR & harming stewardship 💊🔥 • Zero structured surveillance in most LMICs; big data gaps 🗂️🚨 • Cognitive biases (availability, confirmation, ascertainment) worsen misdiagnosis 🧠💭 🎯 Takeaway CNB are a hidden but high-impact threat — common, severe, under-recognized. Better diagnostics, recognition, and surveillance = improved care less unnecessary antibiotics. A major opportunity for global AMS & AMR control 🌍⚡. ijidonline.com/article/S1201…

ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics | Nature Reviews Microbiology (nature.com/articles/s41579-0…)

@IDSAInfo 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients idsociety.org/practice-guide…

✨ Proud to share our team’s contribution at the 20th European AIDS Conference (EACS 2025) in Paris! 🇫🇷 We presented two posters highlighting important regional real-world data from Egypt and Saudi Arabia: 📊 1️⃣ One-Year Clinical Outcomes of Second-Generation Integrase Inhibitors Therapy in Late HIV Presenters in Egypt and Saudi Arabia 📊 2️⃣ Prevalence of Steatotic Liver Disease Phenotypes and Clinically Significant Fibrosis Predictors Among People Living with HIV in the Middle East Region: A Multicenter Study Both studies provide valuable insights into treatment outcomes, metabolic changes, and comorbidities among people living with HIV in our region — reflecting the growing collaboration and commitment to evidence-based HIV care in the Middle East. Grateful to my co-investigators and collaborators from Cairo University and East Jeddah Hospital for their dedication and teamwork, and to the EACS Scientific Committee for the opportunity to share our findings with the global community. #EACS2025 #HIV #Research #Collaboration #InfectiousDiseases #MiddleEast #ClinicalOutcomes #Hepatology #RWE

السلام عليكم ورحمة الله وبركاته اقدم لكم هذا التصميم بتعاون مع شقيقي الدكتور نواف الربيعي هذا التصميم بناءً على طلب بعض الزملاء لإنشاء مخطط لشرح تصنيف المضادات الحيوية حسب آلية العمل. أضفت فيه رموز حسب (Coverage) (Gram , Gram −, Broad spectrum) رموز طريقة الإعطاء (Oral / IV)